Therapeutic management of arthritis: A review on structural and target-based approaches.

Autor: Mahore A; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, New Delhi, India., Kamboj P; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, New Delhi, India., Kaleem M; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, New Delhi, India., Amir M; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, New Delhi, India.
Jazyk: angličtina
Zdroj: Archiv der Pharmazie [Arch Pharm (Weinheim)] 2022 Nov; Vol. 355 (11), pp. e2200182. Date of Electronic Publication: 2022 Jul 18.
DOI: 10.1002/ardp.202200182
Abstrakt: Inflammation is the natural defense mechanism against any external stimuli in the human body and it saves us from foreign entities that may alter our bodies' normal functioning. Any anomaly in this natural defense system leads to the development of different pathological conditions associated with chronic inflammation like rheumatoid arthritis, osteoarthritis, atopy, asthma, allergic rhino-conjunctivitis, coronary artery disease, cardiac arrhythmias, obesity, insulin resistance and type-2 diabetes, depression, and aging. These disorders impair the quality of life of affected people in different ways. Among these, rheumatoid arthritis and osteoarthritis are the most common chronic inflammation-associated disorders. Different therapeutic strategies are already available for the treatment of rheumatoid arthritis and osteoarthritis, but all with pros and cons. Here, we discuss the emergence of several antiarthritic analogs developed by different researchers which could provide the basis for the evolution of newer therapeutic strategies with better activity and safety profiles.
(© 2022 Deutsche Pharmazeutische Gesellschaft.)
Databáze: MEDLINE
Externí odkaz: